Skip to main content
Clinical Trials/NCT02481622
NCT02481622UnknownNot Applicable

Inhibition by the Antibody, First Event of Infection by HIV-1 of Uterine Vaginal Tissue

University Hospital, Strasbourg, France1 site in 1 country600 target enrollmentStarted: November 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
600
Locations
1
Primary Endpoint
identification of the first HIV-infected cells by a histological analysis

Study Overview

Brief Summary

This non-interventional study aims to characterize the cells infected with HIV over time in different types of vagino-uterine tissue.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients whose age ≤50 years and ≥18 years
  • Patients for which surgery like laparoscopy or hysterectomy is necessary as part of a benign pathology.

Exclusion Criteria

  • Patients under 18 years

Outcomes

Primary Outcomes

identification of the first HIV-infected cells by a histological analysis

Time Frame: after surgery, up to 3 weks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

First Event of Infection by HIV-1 of... | Clinical Trial